Based on our finding that fatty-acid-binding proteins are critical for the accumulation of α-synuclein following phosphorylation [17,19,37], we intend to develop more fundamental therapeutics and diagnostic tools for α-synucleinopathies, including Parkinson’s disease, DLB, and multiple system atrophies. This evidence concerns the gene GOT2 and Lewy body dementia.